News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
529,249 Results
Type
Article (10129)
Company Profile (177)
Press Release (518942)
Multimedia
Podcasts (4)
Webinars (7)
Section
Business (180080)
Career Advice (371)
Deals (27772)
Drug Delivery (10)
Drug Development (61414)
Employer Resources (24)
FDA (10435)
Job Trends (9412)
News (261103)
Policy (19861)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (581)
Accelerated approval (28)
ADA (19)
Adcomms (1)
Allergies (118)
Alliances (36625)
ALS (134)
Alzheimer's disease (1083)
Antibody-drug conjugate (ADC) (355)
Approvals (11143)
Artificial intelligence (384)
ASCO (194)
Autoimmune disease (246)
Automation (33)
Bankruptcy (271)
Best Places to Work (7602)
BIO (44)
BIOSECURE Act (2)
Biosimilars (159)
BioSpace Insights (18)
Biotechnology (114)
Bladder cancer (155)
Brain cancer (39)
Breast cancer (535)
Cancer (4209)
Cardiovascular disease (256)
Career advice (306)
Career pathing (3)
CAR-T (222)
CDC (2)
Celiac Disease (1)
Cell therapy (570)
Cervical cancer (37)
Clinical research (55886)
Collaboration (1475)
Commercialization (2)
Compensation (1554)
Complete response letters (38)
COVID-19 (943)
CRISPR (65)
C-suite (894)
Cystic fibrosis (94)
Data (6509)
Denatured (4)
Depression (120)
Dermatology (69)
Diabetes (383)
Diagnostics (4308)
Digital health (38)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (191)
Drug pricing (17)
Drug shortages (2)
Duchenne muscular dystrophy (171)
Earnings (77933)
Editorial (4)
Employer branding (3)
Employer resources (23)
Events (95966)
Executive appointments (843)
FDA (13424)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (27)
Funding (1070)
Gene editing (132)
Generative AI (15)
Gene therapy (347)
GLP-1 (401)
Government (1132)
Grass and pollen (3)
Guidances (321)
Healthcare (9888)
Hematology (129)
HIV (54)
Huntington's disease (26)
IgA nephropathy (71)
Immunology and inflammation (129)
Immuno-oncology (71)
Indications (178)
Infectious disease (1157)
Inflammatory bowel disease (154)
Inflation Reduction Act (5)
Influenza (94)
Intellectual property (265)
Interviews (49)
IPO (13527)
IRA (5)
Job creations (2198)
Job search strategy (289)
JPM (3)
Kidney cancer (20)
Labor market (1)
Layoffs (86)
Leadership (2)
Legal (5393)
Licensing (6)
Liver cancer (51)
Longevity (16)
Lung cancer (624)
Lymphoma (313)
Machine learning (33)
Management (7)
Manufacturing (666)
Marketing (10)
MASH (164)
Medical device (8751)
Medtech (8889)
Mergers & acquisitions (15341)
Metabolic disorders (833)
mRNA (63)
Multiple sclerosis (135)
NASH (7)
Neurodegenerative disease (265)
Neuropsychiatric disorders (50)
Neuroscience (2128)
NextGen: Class of 2026 (3364)
Non-profit (956)
Now hiring (4)
Obesity (260)
Opinion (32)
Ovarian cancer (169)
Pain (189)
Pancreatic cancer (207)
Parkinson's disease (253)
Partnered (11)
Patents (502)
Patient recruitment (614)
Peanut (45)
People (45129)
Pharmaceutical (40)
Pharmacy benefit managers (8)
Phase 1 (17841)
Phase 2 (25015)
Phase 3 (17111)
Pipeline (8019)
Policy (32)
Postmarket research (1706)
Preclinical (7325)
Press Release (41)
Prostate cancer (221)
Psychedelics (8)
Radiopharmaceuticals (249)
Rare diseases (660)
Real estate (3497)
Recruiting (12)
Regulatory (16872)
Reports (19)
Research institute (690)
Resumes & cover letters (48)
Rett syndrome (41)
RNA editing (5)
RSV (49)
Schizophrenia (139)
Series A (178)
Series B (138)
Service/supplier (5)
Sickle cell disease (67)
Spinal muscular atrophy (95)
Sponsored (8)
Startups (2294)
State (1)
Stomach cancer (3)
Supply chain (56)
Tariffs (7)
Vaccines (400)
Venture capital (23)
Weight loss (92)
Women's health (82)
Worklife (1)
Date
Today (43)
Last 7 days (581)
Last 30 days (1649)
Last 365 days (21824)
2026 (13407)
2025 (21841)
2024 (25733)
2023 (29824)
2022 (38097)
2021 (41038)
2020 (36837)
2019 (26171)
2018 (19713)
2017 (21431)
2016 (20447)
2015 (26751)
2014 (23470)
2013 (19525)
2012 (21446)
2011 (21686)
2010 (21502)
Location
Africa (279)
Alabama (84)
Alaska (2)
Arizona (320)
Arkansas (13)
Asia (24908)
Australia (3031)
California (12524)
Canada (3204)
China (1118)
Colorado (491)
Connecticut (458)
Delaware (318)
Europe (40473)
Florida (1871)
Georgia (378)
Hawaii (3)
Idaho (46)
Illinois (747)
India (62)
Indiana (378)
Iowa (15)
Japan (463)
Kansas (104)
Kentucky (30)
Louisiana (29)
Maine (26)
Maryland (1276)
Massachusetts (8526)
Michigan (307)
Minnesota (579)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (12)
Nevada (113)
New Hampshire (64)
New Jersey (2992)
New Mexico (15)
New York (3162)
North Carolina (1436)
North Dakota (4)
Northern California (6328)
Ohio (284)
Oklahoma (18)
Oregon (24)
Pennsylvania (2336)
Puerto Rico (24)
Rhode Island (32)
South America (479)
South Carolina (76)
South Dakota (1)
Southern California (5139)
Tennessee (119)
Texas (1957)
United States (41572)
Utah (369)
Vermont (1)
Virginia (168)
Washington D.C. (41)
Washington State (973)
West Virginia (1)
Wisconsin (84)
529,249 Results for "tlc biopharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OrsoBio Presents Positive Phase 2a Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and MASLD at ENDO 2026
June 15, 2026
·
5 min read
Press Releases
OrsoBio Announces Positive Topline Phase 2a Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and Metabolic Liver Disease
February 10, 2026
·
3 min read
Press Releases
Illuminare Biotechnologies Appoints Veteran Biopharmaceutical Leader as New CEO
July 14, 2026
·
3 min read
Press Releases
OrsoBio Announces Nature Medicine Publication Establishing Clinical and Mechanistic Validation of First-in-Class LXR Inverse Agonist TLC-2716 for the Treatment of Serious Metabolic Diseases
January 16, 2026
·
4 min read
Press Releases
OrsoBio Announces Positive Topline Phase 1b/2a Clinical Data for its Oral Mitochondrial Protonophore TLC-6740 in Combination with Tirzepatide
December 17, 2025
·
5 min read
Press Releases
ILC Dover Introduces EZJetFlo™ Technology to Transform Powder Dissolution and Mixing in Biopharmaceutical Manufacturing
August 6, 2026
·
3 min read
Press Releases
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
June 2, 2026
·
5 min read
Press Releases
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
August 3, 2026
·
15 min read
Press Releases
Provectus Biopharmaceuticals Announces Investor Webinar for 2026 Annual Meeting of Stockholders
June 8, 2026
·
3 min read
Press Releases
DemeRx Strengthens Leadership Team With Appointment of Biopharmaceutical Executive Michael Snitkovsky as Chief Operations Officer
July 7, 2026
·
3 min read
1 of 52,925
Next
